HomePTIXW • NASDAQ
add
Protagenic Therapeutics
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 652.07K | -54.46% |
Net income | -640.78K | 54.12% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -639.49K | 55.29% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.06M | -79.98% |
Total assets | 1.51M | -72.24% |
Total liabilities | 789.32K | -38.34% |
Total equity | 719.01K | — |
Shares outstanding | 6.79M | — |
Price to book | 0.06 | — |
Return on assets | -109.58% | — |
Return on capital | -215.70% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -640.78K | 54.12% |
Cash from operations | -185.66K | 71.69% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | 316.96K | — |
Net change in cash | 131.21K | 298.49% |
Free cash flow | -202.82K | 21.13% |
About
Founded
1994
Website
Employees
2
